Oncotelic Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of OTLC for the last quarter is 0.00 USD, and it's 100.00% lower compared to the previous quarter. The net income of Q4 23 is -735.98 k USD.